Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CYTKCYTK
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CYTOKINETICS INC

GOLDMAN SACHS GROUP INC holds 2.2M shares of CYTK (CYTOKINETICS INC), worth $145.4M as of 2026-Q1. The position was decreased (-7.0% shares). CYTK represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$145.4M

Current Shares

2.2M

Total Value Change

+$88.7M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
2.2M
-7.0%
$145.4M0.0%$60.72
0
2025-Q4
Increased
2.4M
+45.1%
$150.7M0.0%$61.37
41
2025-Q3
Increased
1.6M
+28.3%
$89.8M0.0%$53.89
37
2025-Q2
Decreased
1.3M
-6.5%
$42.1M0.0%$33.16
0
2025-Q1
Increased
1.4M
+13.1%
$54.8M0.0%$43.19
33
2024-Q4
New
1.2M
-
$56.7M0.0%$47.15
41

Other major holders of CYTK: BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used